EyeGate Pharmaceuticals Receives $968,971 New Financing Round

  • Feed Type
  • Date
    9/30/2013
  • Company Name
    EyeGate Pharmaceuticals
  • Mailing Address
    271 Waverly Oaks Road Waltham, MA 02453
  • Company Description
    EyeGate Pharma is focused on replacing ocular injections and other invasive methods of ocular disease treatment. Our goal is to build a pipeline of safer, more effective and patient friendly ocular treatments based on our EyeGate II Delivery System.
  • Website
    http://www.eyegatepharma.com
  • Transaction Type
    Debt
  • Transaction Amount
    $968,971
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.